A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
The First Affiliated Hospital of College of Medicine, Zhejiang University is committed to providing exceptional service through their multidisciplinary care and clinical research.
Hangzhou, China Clinical Trial Location
The First Affiliated Hospital of College of Medicine, Zhejiang University
79 Qingchun Rd, Shangcheng District,
Hangzhou, Zhejiang, China